TL/DR –
The Texas House Select Committee on Health Care Affordability has begun a two-day public hearing to examine the factors driving up healthcare costs in the state. Key issues under discussion include the role of hospital and drug costs, with a particular focus on hospital consolidation and the impact of Pharmacy Benefit Managers (PBMs) in the drug supply chain. The committee also heard evidence about rising health insurance premiums, which have reportedly become voters’ top priority, and the fact that the cost of healthcare in the US is higher than in any other large economy, despite not resulting in better health outcomes.
Healthcare Affordability in Texas
Texas lawmakers are seeking solutions to the growing problem of healthcare affordability for residents. Earlier this year, House Speaker Dustin Burrows initiated the establishment of the House Select Committee on Health Care Affordability. The committee’s objective is to identify and understand the factors contributing to the escalation of healthcare costs in the state.
The committee’s first two-day public hearing focused primarily on hospital and drug costs. Rep. James Frank, the committee’s chair, emphasizes the aim is not just to reduce healthcare costs but also to halt the rampant healthcare inflation that is eating away at the economic lives of Texans.
Charles Miller, director of health and economic mobility policy at public policy organization Texas 2036, highlights that health insurance premiums have surged to an extent where it is now voters’ top priority. A recent poll from KFF, a health issues research organization, supports this viewpoint.
U.S. Healthcare Spending
Despite the U.S. spending more on healthcare than any similar large economy, this investment does not lead to superior health outcomes. Cynthia Cox, senior vice president with KFF, reveals that U.S. healthcare spending is nearly twice the average per person, but results in shorter lifespan when compared to other countries.
Zack Cooper, a professor of public health and economics at Yale University, adds that U.S. healthcare spending has grown three times faster than inflation since 2000. This rapid growth has directly led to a rise in premiums, making healthcare a major portion of people’s salary. Consequently, rising healthcare costs have become one of the leading causes of income inequality in the U.S.
Hospital Consolidation
Loss of competition among hospitals is a rising concern, potentially driving up prices. Anthony DiGiorgio, a neurosurgeon and healthcare policy researcher at the University of California, San Francisco, mentions the significant impact of hospital consolidation. Over 1,300 mergers have occurred among the nation’s approximately 5,000 hospitals since 2000, often leaving independent physicians struggling and patients with reduced local options.
Drug Prices and PBMs
Attention is also drawn to the issue of rising drug costs and the role of pharmacy benefit managers (PBMs) — the ‘middlemen’ in the drug supply chain. PBMs were established to help insurers control prescription drug spending and manage pharmacy benefits. However, consolidation and vertical integration have led many to question their value. In 2023, the four largest PBMs — OptumRx, CVS Health, Express Scripts, and Prime Therapeutics — owned a combined 67% of the national market, often resulting in higher costs for consumers.
The committee continues to welcome public input as they work towards solutions to these multifaceted issues of healthcare affordability in Texas.
—
Read More Health & Wellness News ; US News